1. Home
  2. CRIS vs AERT Comparison

CRIS vs AERT Comparison

Compare CRIS & AERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • AERT
  • Stock Information
  • Founded
  • CRIS 2000
  • AERT 2012
  • Country
  • CRIS United States
  • AERT Singapore
  • Employees
  • CRIS N/A
  • AERT N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • AERT Professional Services
  • Sector
  • CRIS Health Care
  • AERT Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • AERT Nasdaq
  • Market Cap
  • CRIS 21.3M
  • AERT 38.3M
  • IPO Year
  • CRIS 2000
  • AERT N/A
  • Fundamental
  • Price
  • CRIS $1.88
  • AERT $1.04
  • Analyst Decision
  • CRIS Strong Buy
  • AERT
  • Analyst Count
  • CRIS 2
  • AERT 0
  • Target Price
  • CRIS $16.50
  • AERT N/A
  • AVG Volume (30 Days)
  • CRIS 153.9K
  • AERT 328.5K
  • Earning Date
  • CRIS 07-31-2025
  • AERT 08-14-2025
  • Dividend Yield
  • CRIS N/A
  • AERT N/A
  • EPS Growth
  • CRIS N/A
  • AERT N/A
  • EPS
  • CRIS N/A
  • AERT N/A
  • Revenue
  • CRIS $11,202,000.00
  • AERT $70,198,000.00
  • Revenue This Year
  • CRIS N/A
  • AERT N/A
  • Revenue Next Year
  • CRIS $10.67
  • AERT N/A
  • P/E Ratio
  • CRIS N/A
  • AERT N/A
  • Revenue Growth
  • CRIS 14.17
  • AERT N/A
  • 52 Week Low
  • CRIS $1.02
  • AERT $0.46
  • 52 Week High
  • CRIS $8.29
  • AERT $2.93
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 41.14
  • AERT 53.28
  • Support Level
  • CRIS $1.50
  • AERT $1.03
  • Resistance Level
  • CRIS $1.90
  • AERT $1.32
  • Average True Range (ATR)
  • CRIS 0.20
  • AERT 0.18
  • MACD
  • CRIS -0.06
  • AERT -0.02
  • Stochastic Oscillator
  • CRIS 35.51
  • AERT 22.40

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

Share on Social Networks: